Healthcare provider profile · identity verified

Robert Norman Blanche, M.D.

Internal Medicine · MEDFORD, OR · NPI 1477567659

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	362	42
Memantine Hcl	Memantine Hcl	353	38
Gabapentin	Gabapentin	253	26
Metoprolol Succinate	Metoprolol Succinate	204	25
Lisinopril	Lisinopril	178	19
Omeprazole	Omeprazole	178	21
Donepezil Hcl	Donepezil Hcl	174	20
Furosemide	Furosemide	166	22
Amlodipine Besylate	Amlodipine Besylate	150	19
Eliquis	Apixaban	149	21
Metformin Hcl Er	Metformin Hcl	145	16
Rivastigmine	Rivastigmine	141	18
Levothyroxine Sodium	Levothyroxine Sodium	139	16
Oxycodone Hcl	Oxycodone Hcl	124	36
Rosuvastatin Calcium	Rosuvastatin Calcium	108	11
Potassium Chloride	Potassium Chloride	107	14
Duloxetine Hcl	Duloxetine Hcl	93	11
Citalopram Hbr	Citalopram Hydrobromide	83	suppressed
Trazodone Hcl	Trazodone Hcl	83	13
Pantoprazole Sodium	Pantoprazole Sodium	79	suppressed
Risperidone	Risperidone	73	12
Tamsulosin Hcl	Tamsulosin Hcl	72	11
Sertraline Hcl	Sertraline Hcl	69	suppressed
Finasteride	Finasteride	64	suppressed
Trulicity	Dulaglutide	62	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	59	suppressed
Losartan Potassium	Losartan Potassium	56	suppressed
Carvedilol	Carvedilol	54	suppressed
Cephalexin	Cephalexin	52	34
Mirtazapine	Mirtazapine	52	suppressed
Levetiracetam	Levetiracetam	51	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	50	suppressed
Olanzapine	Olanzapine	50	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	13
Risperidone Odt	Risperidone	45	suppressed
Famotidine	Famotidine	44	suppressed
Simvastatin	Simvastatin	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	suppressed
Divalproex Sodium	Divalproex Sodium	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Metformin Hcl	Metformin Hcl	40	suppressed
Ondansetron Odt	Ondansetron	40	19
Pioglitazone Hcl	Pioglitazone Hcl	40	suppressed
Allopurinol	Allopurinol	39	suppressed
Spironolactone	Spironolactone	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	16
Klor-Con 10	Potassium Chloride	35	suppressed
Lidocaine	Lidocaine	35	16
Prednisone	Prednisone	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Torsemide	Torsemide	33	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	30	16
Aripiprazole	Aripiprazole	30	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	22	suppressed
Trospium Chloride	Trospium Chloride	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Oxycontin	Oxycodone Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Leflunomide	Leflunomide	16	suppressed
Perphenazine	Perphenazine	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Topiramate	Topiramate	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Digoxin	Digoxin	15	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Glipizide	Glipizide	15	suppressed
Morphine Sulfate	Morphine Sulfate	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Estradiol	Estradiol	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Baclofen	Baclofen	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Klor-Con M15	Potassium Chloride	12	suppressed
Lorazepam Intensol	Lorazepam	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Valsartan	Valsartan	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Galantamine Hydrobromide	Galantamine Hbr	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error